3 unknown, 1 completed. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Unknown 3, Completed 1 |
| Phase 2 | 3 | Unknown 3 |
Follow Aronex Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies Aroplatin (Liposomal NDDP) in combination with capecitabine - Colorectal Neoplasms | Phase 1 / Phase 2 | Unknown | Aronex Pharmaceuticals | 105 | 2005-06-24 | |
| Safety and Effectiveness of Zintevir (AR177) Given to HIV-Infected Patients Zintevir - HIV Infections | Phase 1 | Completed | Aronex Pharmaceuticals | 12 | 2005-06-24 | |
| Aroplatin and Gemcitabine in Patients With Advanced Pancreatic Cancer Resistant to Standard Therapies Aroplatin (Liposomal NDDP, L-NDDP) - Pancreatic Neoplasms | Phase 1 / Phase 2 | Unknown | Aronex Pharmaceuticals | 111 | 2005-06-24 | |
| A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies Aroplatin (Liposomal NDDP, L-NDDP) - Esophageal Neoplasms, Hepatocellular Carcinoma | Phase 1 / Phase 2 | Unknown | Aronex Pharmaceuticals | 40 | 2005-06-24 |
Colorectal Neoplasms (2) · Neoplasm Metastasis (2) · Pancreatic Neoplasms (2) · Carcinoma, Hepatocellular (1) · Esophageal Neoplasms (1) · HIV Infections (1) · Neoplasms (1) · Ovarian Neoplasms (1)
bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II) (3) · Capecitabine (1) · T 30177 (1)
United States (2)